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Differences in X-Chromosome Transcriptional Activity
and Cholesterol Metabolism between Placentae from
Swine Breeds from Asian and Western Origins
Steve R. Bischoff1,2,3¤a, Shengdar Q. Tsai1,3¤b, Nicholas E. Hardison4, Alison A. Motsinger-Reif4,
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Abstract
To gain insight into differences in placental physiology between two swine breeds noted for their dissimilar reproductive
performance, that is, the Chinese Meishan and white composite (WC), we examined gene expression profiles of placental
tissues collected at 25, 45, 65, 85, and 105 days of gestation by microarrays. Using a linear mixed model, a total of 1,595
differentially expressed genes were identified between the two pig breeds using a false-discovery rate q-value #0.05.
Among these genes, we identified breed-specific isoforms of XIST, a long non-coding RNA responsible X-chromosome
dosage compensation in females. Additionally, we explored the interaction of placental gene expression and chromosomal
location by DIGMAP and identified three Sus scrofa X chromosomal bands (Xq13, Xq21, Xp11) that represent
transcriptionally active clusters that differ between Meishan and WC during placental development. Also, pathway analysis
identified fundamental breed differences in placental cholesterol trafficking and its synthesis. Direct measurement of
cholesterol confirmed that the cholesterol content was significantly higher in the Meishan versus WC placentae. Taken
together, this work identifies key metabolic pathways that differ in the placentae of two swine breeds noted for differences
in reproductive prolificacy.
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maternal uterine stroma and is classified as a diffuse epitheliochorial [4]. The placenta forms the maternal-fetal transport interface
and sensitizes the developing fetus to environmental perturbations;
indeed, pregnancies irrespective of identical genetic background,
e.g. same mother, can significantly vary by litter size, fetal birth
weights and placental weights. When compared to commercial
western breeds of pigs such as the white composite breed (WC), the
Chinese Meishans farrow three to five more piglets per litter, and
this enhanced prolificacy has been attributed to major differences
in placental morphology and physiology [5,6]. Increased placental
vascularization and reduced uterine surface area, are thought to
account for increased nutrient exchange to the Meishan fetus, and
is predicted to yield larger litter sizes, albeit with lower birth
weights [7]. Thus, both its simplicity and the existence of breed-tobreed variation provide a unique tool to examine how gene
expression profiles relate to breed-specific placental function.

Introduction
The placenta serves as a critical transport organ between the
developing fetus and mother to regulate nutrient exchange,
excretion of waste, oxygen and hormones [1]. Interactions among
transcriptional/epigenetic circuits and environmental cues influence intrauterine growth and may lead to aberrant physiological
programs in the adult through fetal programming [2]. Dissecting
trophoblast physiology pathways by functional genomic tools
could help to clarify how the fetus is sensitized to environmental
inputs, such as undernutrition or uterine crowding, and alleviate
pregnancy complications and in utero programming of adult
diseases.
Due to its simplicity, the swine placenta provides an excellent
model to study some of the fundamental factors that affect
maternal-fetal-placental function [3]. The porcine placenta
consists of an epithelial bilayer with no active invasion into the
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examination of X-inactivation as well as comparisons with a
previously generated female-only dataset (8).

Additionally, improvements in swine reproductive fitness can
impact food production as the incidence of stillborn, growthrestriction and postnatal morbidity limits fecundity and raises
agribusiness costs [8]. Major losses during swine embryonic
development primarily occur prior to day 40 of gestation [9,10].
Genetic selection strategies have identified rate-limiting determinants for maximizing number of piglets, which include ovulation
rate, fertilization rate, pre-implantation embryonic survival,
placental efficiency and post-natal health [11,12]. Enhancement
of ovulation rate reduces early embryo viability attributed to
uterine crowding and low egg quality [13]. Furthermore, breeding
schemes that select sows with larger litters result in low-birth
weight piglets and higher incidence of postnatal mortality [14].
Building on our previous studies [15], we surveyed differential
placental gene expression between White Composite (WC) and
Meishan (MS) breeds throughout gestation at 20-day intervals
(days 25, 45, 65, 85 and 105) to identify historic breed differences
throughout the gestational period. Using functional genomics
classification tools, we identify cholesterol biosynthesis and
transport as major functional pathways that differ in the placentae
of each breed. Furthermore, we present an intriguing molecular
phenotype between breed placentae by mapping transcriptionally
active clusters across the X-chromosome and RNA structural
differences in XIST.

3 Fetal Tissue Collection and RNA Isolation
Briefly, naturally mated WC or Meishan gilts were sacrificed to
collect fetal tissues at 20-day gestational intervals including days
25, 45, 65, 85 and 105 (D25, D45, D65, D85, D105) at the
USMARC abattoir according to USDA regulations. The WC
placental samples were derived from control line gilts in a serial
slaughter experiment as described in Freking et al. 2007 [20].
Meishan gilts were matched to the same slaughter ages represented. The Meishan gilts were housed and reared separately in similar
breeding and gestation pen facilities and were fed similar diets. For
sampling consistency, sections of 262 cm2 chorioallantoic (placental) tissues were dissected cleanly away from maternal
endometrium or fetal amnion. Biopsied placental tissues were
sourced dorsal to the fetal amnion, harvested within 5–8 minutes,
flash-frozen in liquid nitrogen, and stored at 280uC until further
processing. Handling of animals complied with the procedures as
specified in [21]. Animal protocols were approved by the
Institutional Animal Care & Use Committee at North Carolina
State University and the USMARC-ARS-USDA. The procurement, care, and use of animals were in accordance with the
regulations and terms of the federal Animal Welfare Act and the
Health Research Extension Act of 1985, and subsequent revisions.
All research projects and educational or extension activities using
vertebrate animals under the jurisdiction or control of NCSU are
reviewed and approved by the Institutional Animal Care and Use
Committee (IACUC).
Frozen tissues were pulverized by mortar and pestle in
preparation for RNA extraction. After tissue disruption, total
chorioallantoic RNA from both WC and Meishan animals were
isolated according to a commercial kit with minor modifications
(RNAqueous kit, Ambion, Austin, TX). Briefly, 100 mg pulverized
tissue was immediately added to 1.2 ml RNA lysis and stabilization buffer [4 M LiCl, 5% Triton-X100, 5% DGME, 10 mM
EDTA, 50 mM TCEP, 1% Na2WO4, 100 mM HEPES at
pH 8.8] (W509043, DMGE; Sigma, St. Louis, MO) contained
the sulfhydryl reductant tris-2-carboxyethyl phosphine 50 mM
(TCEP; PolyOrganix, Houston, TX; ) in lieu of dithiothreitol [22],
and acid phenol:BCP (B9673, Sigma, St. Louis, MO) extraction
was omitted from all isolation steps. Total RNA was selectively
precipitated with 6 M LiCl and 10 microgram total RNA aliquots
were stored in 1 mM sodium citrate, pH 6.4 at 280uC to preserve
integrity until microarray hybridization or quantitative real-time
reverse-transcription PCR (RT-qPCR). Quantitation by UVspectrophotometry of A260/280 ratios, an indicator of RNA
purity, generally exceeded 1.90, and A260/230 ratios (organic
contamination) were generally greater than 2.0 as gauged by
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). RNA quality was judged by ribosomal
banding 28:18 Svedberg ratios from denaturing 1% agarose
lithium acetate gels or RNA integrity scores (RIN) of 9 or better
using a commercial chip analyzer (RNA Lab-on-a-chip, Agilent
2100 BioAnalyzer).

Materials and Methods
1 Breed Description
A four-breed composite population, namely white composite
(WC), derived from maternal lines consisting of 1/4 Yorkshire, 1/
4 Landrace, 1/4 Large White, and 1/4 Chester White breeds was
used to provide placental tissue. This population averaged 9 piglets
per litter and birth weights of 1117 g from gilt matings.
Reproductive performance of the WC USDA-MARC population
used in this study has been described previously by Cassady and
colleagues [16]. Noted for their enhanced fecundity, Meishans as
well as Fenjing, Jiaxing-Black and Erhualian are derived from the
Taihu strain and are native to the Yangtze River basin. The
USDA obtained Meishan germplasm in 1989 as a gift from the
Chinese government and remains as a restricted bioresource due
to its status as a natural treasure [17]. Reproductive performance
of Meishans (MS) obtained from this germplasm has been
summarized previously [17,18]. At approximately 90 days, MS
become sexually mature; gilts farrow 14–17 piglets on average,
and birth weights average 900 g [17]. All animal tissues used for
these studies were derived from cohorts maintained at ARSUSDA-MARC and described in the aforementioned references.

2 Experimental Design
To determine overall breed differences independent of gestational age, each breed was sampled at five different time points
(D25, D45, D65, D85 and D105) with three biological replicates
per time point, for a total of fifteen replications per breed.
Biological replicates consisted of three randomly selected female
placentas from each pregnancy. The time points were selected to
cover all periods of gestation starting from D25 when the placenta
is fully formed. This design allowed us to look at overall breed
differences independent of stage of gestation, as well as temporal
differences. Additionally, fetuses were sexed either visually (D65,
D85, and D105) or by PCR (D25 and D45) using primers to SRY
or X-specific AMELX or Y-specific AMELY [19]. Females were
chosen with the exception of one male sample at D65_MS_B
(GEO accession GSM264145) due to sample limitations (only two
females in the D65 litter). The choice of females allows closer
PLOS ONE | www.plosone.org

4. Microarray Analyses
4.1 In vitro transcription and hybridization to affymetrix
porcine GeneChip. A detailed description of in vitro transcrip-

tion to produce cRNA and its hybridization to short-oligonucleotide arrays (900623, Porcine GeneChip, Affymetrix, Santa Clara,
CA) is previously described in Bischoff et al, 2008 [15]. The array
contains 23,937 probe sets that interrogate approximately 23,256
transcripts from 20,201 Sus scrofa genes. The data discussed in
2
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this publication have been deposited in NCBI’s Gene Expression
Omnibus (GEO) [23], and the Affymetrix Porcine GeneChip *.cel
files are accessible through GEO Series accession numbers
GSE10446, GSE10447. Datasets used in this publication are
compliant with the standards adopted by the MIAME consortium
for reporting microarray datasets.
4.2. Statistical modeling of gene expression. Minimal
normalization was performed using a linear-mixed model
normalization procedure [24,25] to essentially re-center the mean
intensity of each expression array. Log2-transformed perfectmatch (PM) intensities for all observations were fit to a linear
mixed model [24,25]. A gene-specific mixed model was fit to the
normalized intensities (residuals from first model) accounting for
fixed breed, probe, and breed-by-probe interaction effects and a
random array effect. A description of fixed and random effects is
described elsewhere [25,26]. To discover the magnitude and
significance of differential expression between pig breeds at the
transcript level, we implemented JMP Genomics 5.0 (SAS, Cary,
NC) using analysis of variance (ANOVA), e.g. PROC MIXED as
implemented in SAS, while correcting for multiple tests and
adjusting for covariates and random effects [27]. A normal
distribution of the random error e is assumed with its center at
zero. Specifically, differential expression was determined by the
following ANOVA model using JMP Genomics 5.0:

5 Extraction of Endothelial Biomarkers from Array
Datasets to Indirectly Assess Breed-specific Placental
Vascularity Differences
In order to indirectly determine the degree of placental
vascularization by examining the normalized expression level of
endothelial cell markers, we compared expression of CDH5 (VEcadherin), ENG (endoglin), COLEC11 (collectin sub-family
member 11), FLT1 (FMS-like tyrosine kinase 1/vascular permeability factor receptor) and PECAM1 (platelet endothelial cell
adhesion molecule) [38,39], all known endothelial cell biomarkers.

6 Validation of Microarray Data by Real-time Quantitative
Reverse Transcription Polymerase Chain Reaction (RTqPCR)
6.1 Production of first-strand cDNA. Total RNA 200 ng
ml21 was pretreated with 3 ml (2 U ml21) hypermorphic DNase I

[37uC, 609] (AM2239, Turbo DNase, Ambion/Applied Biosystems, Austin, TX). First-strand cDNA synthesis was conducted
using 5 mg total RNA, oligodTn = 20 with slight modifications to the
thermocycling parameters [42uC @109; 50uC @ 59; 55uC @ 59;
42uC @ 909] and reaction master mixes contained a thermostable,
RNase H-null reverse transcriptase (600109, AffinityScript,
Stratagene/Agilent, LaJolla, CA), a hypermorphic RNase inhibitor (No. AM2696, SUPERase In, Ambion, Austin, TX) was
substituted in lieu of the placental ribonuclease inhibitor and
addition of thermostable single-stranded binding protein (ET-SSB,
H0230S, Biohelix, Beverly, MA).
6.2 EvaGreen two-step RT-qPCR. To evaluate the quality
of PCR primers for RT-qPCR assays, efficiency curves were
generated by serial dilution (1:3, 1:6, 1:9) of cDNA from the firststrand reaction, and only efficiencies ranging 95–105% were
considered (data not shown). To identify candidate housekeeping
genes, expression criteria included moderate to high expression,
invariant across gestational time points, and ideally spanned exonintron junctions. RPL18 [40,41] and RPS20 [42] were identified as
housekeeping genes based on these criteria.
A two-step master mix (No. 172–5203, SsoFast EvaGreen
Supermix, BioRad, Hercules, CA) containing an enhanced
double-stranded DNA fluorescent dye was chosen based on
flexibility to change array target sequences and compatibility with
thermocycler (iCyclerH iQ, BioRad, Hercules, CA). The addition
of 4 ng ml21 thermostable single-stranded DNA binding protein
(No. M2401S, ET-SSB, Biohelix, Beverly, MA) was added as it has
been previously shown to improve PCR multiplexing and
specificity. Triplicate biological samples with technical duplicates
of 25 ml RT-qPCR reactions [initial denaturation 95uC for 2
minutes, (95uC @ 150, 57uC @ 150, 72uC @150)n = 40 cycles] were
run using 33 ng oligo-dTn = 20-primed first-strand D25, D45, D65,
D85 and D105 cDNA and 500 nanomolar primers (Table S1).
A melting curve [98uC, 20.1uC second21] was examined by
plotting temperature on the x-axis and the derivative of EvaGreen
fluorescence over temperature (2dF/dT) on the y-axis to verify
correct amplification. In each case, examination of melting curves
and visualization by SYBR Gold (S-11494, Molecular Probes,
Eugene, OR) staining on 2% agarose 10 mM Li2B4O7, pH 6.5 gel
electrophoresis [43] yielded RT-qPCR amplicons of representative
Tm or product size as compared to a DNA ladder (No. N3200L, 2log DNA ladder, New England BioLabs, Ipswich, MA). Nontemplate negative controls were verified as negative after 40 cycles.
6.3 Statistical analysis of RT-qPCR. Reverse-transcription
quantitative PCR (RT-qPCR) was employed to confirm arraybased gene differential expression essentially as described in Tsai
et al 2006 [38] using comparative CT method, where fold change

expression~breedzprobezbreedxprobezearray ze
We used a perfect-match only gene-by-gene model, as some
reports indicated that incorporating the mismatch probes increases
noisiness of the data when estimating differential expression
[28,29]. JMP 5.0 software was executed according to the default
settings described by the version 5 software workflow to calculate
estimate statements for breed comparisons using all thirty arrays.
To correct for multiple testing, we implemented Storey’s
procedure [30,31] by conversion of p-values from linear-mixed
model procedures to q-values using QVALUE (software downloaded from [32]. Comparisons between treatment group (breed)
for differential gene expression were made based on the following
criteria: 1) statistical cut-off of q-value ,0.05 for false discovery
rates (FDR), and 2) a stringent presence threshold p-value ,0.001
as calculated by the MAS 5.0 present/absent algorithm using the
following equation:
PM{MM
PM~perfect match; MM~mismatched probes½33:
PMzMM

Using JMP 8.0/JMP Genomics 5 software (SAS, Cary, NC)
principal component analysis (PCA) [34] was used to rapidly
visualize the similarity of the placental transcriptional signatures
[35] observed across the thirty arrays. Scatter plots, e.g. volcano
plots of fold-change (log2-transformed data estimates) versus
significance [–log10(p-values)], were constructed to rapidly identify
gene expression differences in Meishan (positive) and WC
(negative) placentae. We used an updated annotation of the
porcine Affymetrix microarray platform as described in [36] with
improved annotation to Sus scrofa genome build 9.2 available at
reference [37].
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= 22(DDCT) [(CT gene of interest2CT internal control) Meishan –
(CT gene of interest2CT internal control) WC)] [44,45].
Established pregnancies from a single gilt per breed were used
to screen placental gene expression from three littermates (three
biological replicates per breed) by RT-qPCR. For each biological
replicate, at least two technical replicates were used: 2 breeds 63
biological replicates 62 technical replicates. A two-tailed heteroscedastic (unequal variance) Student t-test was used to determine
significance (p,0.05) and standard error was calculated from
observed Ct levels per breed [46].

then sonicated to homogeneity (3–5 pulses, 10-seconds, 800W).
The placental tissues were diluted with an equal volume of
phosphate buffer saline, and equal volumes of aliquots were made
to analyze free cholesterol, esterified cholesterol, and bulk cellular
protein. Samples were normalized according to total amount of
bulk cellular protein using UV spectroscopy at 280 nm or a
modified Bradford assay (No. 500-0001, Bio-Rad Protein Assay,
Bio-Rad, Hercules, CA). Triplicates of controls and samples were
measured at emission 590 nm for the Amplex Red assay. For
control experiments, a standard curve was performed as described
by the manufacturer’s protocol and a regression line was fit with
adjusted R-square = 0.989 for cholesterol concentrations ranging
from 0–10 micromolar (data not shown). Samples were diluted in
1X PBS to be within the linear range of the standard curve.

7 PCR Analysis of XIST Genomic Locus and mRNA
Expression
In experiments to confirm XIST presence in genomic DNA and
RNA isoform screens by PCR, three biological replicates per
breed (genomic DNA: 3 MS, 3 WC; cDNA: 3 Meishan, 3 White
Composite) were used. We used a thermostable DNA polymerase
fused to the processivity factor Sso7d (Pfu:Sso7d, No. F-549L,
HotStart Phusion II or No. F-122L, Phire II, New England Labs,
Ipswich, MA), and thermocycling conditions were used according
to the manufacturer’s protocol [47–49]. A list of primers (25 nmole
synthesis, desalting only; Integrated DNA Technologies, Coralville, IA) used in this study and target sequence accessions is
provided in Table S1.

Results
1 Comparisons of Meishan Versus WC [MS vs. WC]
Placental Gene Expression Profiles during Fetal
Development
1.1 Principal component analysis (PCA) of 30 shortoligonucleotide arrays. For initial exploratory analysis of the

thirty placental gene expression arrays, PCA [34,59] was
performed using JMP Genomics. Figure S1 depicts the first three
principal components and each component explains variance
across all microarrays, respectively. At each of the gestational
intervals, microarrays cluster by gestational day and also by breed.
In general, with the exception of D25 samples, each breed/date
combinations cluster separately. We also note the array containing
a male fetus at D65 (D65_M_B) shows similar larger variance to
female-only sample D65_M_C sample.

8 Functional Enrichment Analysis
8.1 Gene ontology analysis. Gene functional classification
using DAVID [50,51] and pathway analysis using KEGG and
Ingenuity were performed as described [34,52,53]. To assist with
the selection of gene ontology (GO) software suited for our
microarray datasets, we used the freely available SerbGO [54] and
identified the Database for Annotation, Visualization, and
Integrated Discovery, commonly referred to as DAVID [50].
Differentially expressed genes at q-value ,0.05 from breed
analyses (Meishan – White Composite) were used as data input.
8.2 Ingenuity pathway analysis (IPA). Briefly, pathways
from the Ingenuity library of canonical pathways that were most
significant to the data set were identified. Molecules from the data
set that met the q ,0.05 cut-off and were associated with a
canonical pathway in Ingenuity’s Knowledge Base were considered for the analysis. The significance of the association between
the data set and the canonical pathway was measured in two ways:
1) a ratio of the number of molecules from the data set that map to
the pathway divided by the total number of molecules that map to
the canonical pathway; 2) Fisher’s exact test was used to calculate a
p-value determining the probability that the association between
the genes in the dataset and the canonical pathway is explained by
chance alone (IngenuityH Systems, www.ingenuity.com). A
description of IPA symbols and glyphs is provided in Figure S3.
8.3 Additional bioinformatics analysis tools. To better
understand isoform transcript structure and gene behavior, we
utilized Aceview [55] and WikiGene [56]. To facilitate mapping
genes by chromosome location, we used our annotated microarray
data sets with DIGMAP [57]. Briefly, Affymetrix probes were
converted to chromosomal locus coordinates using the Sus scrofa
genome build 9.2 available at Ensembl [58].

1.2 Volcano plot depicts breed specific differences of MS
vs. WC placental gene expression profiles during fetal
development. In order to visualize genes differentially ex-

pressed between the two breeds, volcano plots were used to show
estimates of change (abscissa, log2-transformed) against significance (ordinate axis, 2log10-transformed) between Meishan and
WC breed placental tissues (Figure 1). Positive estimates correspond to genes up-regulated in Meishans. In the upper right
(Meishan, upregulated) and upper left (WC upregulated) corners of
the volcano plot are gene products expressed at greater than a twofold change (vertical dashed lines) and cyan-colored probe sets are
labeled for convenience where q-value ,0.05. It should be noted,
that these differences are not due to a single probe hybridization
defect as the linear mixed model contained a covariate to account
for identified probe-by-breed effects [15].
A total of 1,595 genes were differentially expressed (log2transformed, q-value #0.05, Figure 1, Table S2) in the combined
analysis comparing breed across all time points. ABCA1–a
cholesterol efflux regulatory protein–and XIST–a long non-coding
RNA involved in X-chromosome inactivation–were highly
expressed in the WC placentae. By comparison, formin (FMN1),
a cartilage glycoprotein (chitinase 3-like 1; CHI3L1), and TACC1
(transforming, acidic coiled-coil containing protein 1) were highly
expressed in MS placental tissues and are implicated in cell
adhesion, remodeling and structural architecture of the placenta.
Comparisons of the differentially expressed genes (log2-transformed, q ,0.05) by breed are summarized in Table S2.
Whenever possible, a description of gene function or protein
activity is provided for top candidates that showed significant
expression differences.

9 Analysis of Cholesterol Concentrations
Free and esterified cholesterol concentrations were measured by
the fluorometric Amplex Red cholesterol assay (No. A12216, CAS
119171-73-2, Life Technologies, Carlsbad, CA) according to the
manufacturer’s protocol with minor modifications. Briefly, ,1
gram of frozen placental tissues were allowed to thaw on ice and
PLOS ONE | www.plosone.org
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analysis using bovine XIST (genbank accession: NR_001464.2)
identified multiple probe sets (Ssc.31029.1.A1_at, Ssc.2434.1.A1_at
and Ssc.13426.1.A1_at), which mapped to the 39 region of the
bovine XIST confirming the correct annotation of the array
probes. For clarity, an illustration of the putative swine XIST
mRNA is shown in Figure 2A.
As X-inactivation is initiated at the XIST gene locus by an
inside-out mechanism [64], we hypothesized that neighboring
genes known to be inactivated by XIST should be upregulated in
Meishan expression profiles due to abnormal X-inactivation.
Expression of ten dosage-compensated genes (HSD17B10, KLF8,
MSN, MTCP1, OCRL, SLC25A6, SLC25A5, SNX12, RBBP7 and
TIMM17B) was examined by microarray linear-mixed model
analysis. Seven dosage-compensated genes were not upregulated
in Meishans placentae (MSN, MTCP1, OCRL, RBBP7, SLC25A6,
SNX12, and TIMM17B) supporting that the XIST is functional in
Meishan placentae, thus placing the microarray XIST expression
results into question. As multiple XIST 39-ESTs were identified by
our transcriptome profiling at D25, D45, D85, D105 gestational
intervals, we sought to clarify if XIST expression was concordant
with our array findings by using RT-qPCR (Table 1). Similar
trends in fold-change were observed by both methods, and
therefore validate our microarray observations.
Because we were unable to detect 39 regions of XIST by both
microarray and RT-qPCR in Meishans, we next sought to clarify
if 59 regions were detectable. Human EST databases support at
least 10 human XIST spliced variants, and multiple XIST isoforms
that differ by truncation of both 59 and 39 ends [55]. Importantly,
Wutz et al 2002 [65] identified a series of stem-loops within
conserved XIST exon 1 (A-repeat region) required for chromosomal silencing, and subsequent reports have shown the 59 A-stem
loops are necessary and sufficient to recruit polycomb repressive
complex machinery, facilitate splicing of XIST RNA, and maintain
random X-inactivation. We designed a series of RT-PCR’s to
investigate whether the functionally conserved element (A-stem
loops) of porcine XIST is present in Meishans and expressed in
Meishans (Table 1 and Figure 2). We also examined whether the
inability to detect the 39 end of the Meishan XIST transcript was
due to a genomic deletion. As shown in Figure 2, there were no
structural differences between the two breeds in the regions
examined, and the data indicates that the 39 end of the XIST is
present, but not transcribed, in the Meishan breed. Combined
these data suggest that while the XIST gene appears to be
processed differently between the breeds (short isoform in the MS);
in both cases, it is capable of X-inactivation.

Figure 1. Differential placental gene expression in Meishan
versus WC swine breeds. Volcano plots were used to visualize
differential expression between Meishan and White Composite
placental tissues against level of significance surveyed for breed
specific differences. The x-axis is the log2 fold-change difference of the
Meishan minus WC breed groups. The vertical axis represents the
statistical evidence as a measure of the –log10 transformation of the pvalue for each test of differences between samples. Each of the ,24,000
oligonucleotide probe sets is plotted. A red dashed line indicates the
FDR adjustment (approximately q-value ,0.05) to correct for multiple
testing. Blue dashed lines showed estimates of 1, and 21, which
corresponds to a 2-fold (inverse natural logarithm of estimates) increase
or decrease respectively.
doi:10.1371/journal.pone.0055345.g001

2 Microarray Validation
In addition to using principal component analysis (Figure S1)
and array group correlations to assess the quality of our
microarray hybridization data (data not shown) [60], we sought
to evaluate the short-oligonucleotide microarray results by the
orthogonal reverse-transcription quantitative polymerase chain
reaction (RT-qPCR) method as outlined by the Microarray
Quality Control (MAQC) project [61,62]. The housekeeping
genes RPL18 and RPS20 were used as internal controls to compare
across samples and similar amplification efficiencies (.95%) were
observed for all primers used. A summary of RT-qPCR results is
presented in Table 1. The direction of fold change is concordant
with microarray results and thus validates the microarray findings.
We also explored a subset of cholesterol pathway genes by RTqPCR, and these results were also concordant with microarray
findings (discussed in Results, Section 3.8).

4 Breed-specific X-chromosome Regional Gene
Expression Differences
In order to determine whether there were other breed
differences with respect to the X chromosome, regional differences
in gene expression were determined. A bubble plot of X
chromosome location versus sign-ranked significance modeling
only for breed effect is presented in Figure 3. Additionally,
differential gene locus mapping (DIGMAP) [57] was used to
determine if the differentially expressed genes were randomly
distributed along the X chromosome or located in specific regions.
As shown in Figure 3 and Table 2 several clusters or enriched
regions were identified. The chromosomal band Xq13 (p-value
,2.29E-04) corresponding to genes CHIC1, DLG3, IL2RG, OGT,
PIN4, RNF12, RPS4X, SH3BGRL, SNX12, TAF9B, XIST, YIPF6
and ZMYM3 ranked highest by criteria of placental gene
expression and chromosomal location. Also, the Xq13 interval
has been associated with several quantitative trait loci (QTL)
including pig fat deposition and carcass musculature [12,66–70].

3 Expression of XIST in Meishan and White Composite
Breeds
XIST, a long non-coding RNA that facilitates X-chromosome
inactivation (XCI) to balance sex chromosomes in placental
mammals [63], and that has been shown to be imprinted in
extraembryonic tissues, was differentially expressed between the
two breeds with virtually no detection in the MS breed at any time
point. Non-coding RNAs are known to be less-conserved than
protein-coding sequences; however, re-annotation by BLAT
PLOS ONE | www.plosone.org
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Table 1. EvaGreen RT-qPCR analysis of select genes across placental datasets.

Gene

ABCA1

Gene Description

Probe

Description

Day

N

ATP-BINDING

Ssc.7146.A1_a1

Cholesterol Efflux

25

6

0.14

0.30

26.63

3.11E–41

45

6

0.10

0.21

23.65

2.55E–31

65

6

0.24

0.86

24.40

7.15E–41

85

6

0.08

0.63

25.32

6.21E–31

105

6

0.17

0.60

28.15

3.955E–31

25

6

0.68

0.42

21573.8

3.08E–021

45

6

0.19

0.25

214.02

5.38E–081

65

6

0.60

0.96

2138.14

4.28E–021

85

6

0.31

0.69

22149.8

3.82E–021

105

6

0.44

0.41

2576.03

1.47E–021

25

6

0.30

0.56

22.19

5.11E–061

45

6

0.45

1.00

21.84

1.46E–041

65

6

0.59

0.95

21.12

3.56E–021

85

6

0.35

0.28

24.72

1.82E–021

CASSETTE

TRANSPORTER MEMBER

XIST*

Student t-Test
DCt
(Normalization)

Std Err Std Err Fold Change
MS
WC
(MS-WC)

1

X (INACTIVE)-SPECIFIC

Ssc.2434.1.A1_at

X-Cs inactivation

TRANSCRIPT

XIST*

X (INACTIVE)-SPECIFIC

Ssc.31029.1.A1_at

X-Cs inactivation

TRANSCRIPT

PHLDA2

PLECKSTRIN HOMOLOGY-LIKE

CDKN1C

CYCLIN-DEPENDENT KINASE

DOMAIN, FAMILY

INHIBITOR

A,

MEMBER

105

6

0.25

0.23

21.68

3.67E–021

Ssc.9796.1.A1_at

Genomic Imprinting

65

6

0.57

0.82

2.27

1.48E–021

Ssc.8871.1.S1_at

Genomic Imprinting

65

6

0.15

0.29

1.82

4.08E–061

2

1C (P57, KIP2)

RPS20

RIBOSOMAL PROTEIN

S20

Ssc.20036.1.S1_at

Internal Reference

65

6

0.49

0.07

–

–

RPL18*

RIBOSOMAL PROTEIN

L18

Ssc.10553.1.A1_a_at

Internal Reference

25

6

0.38

0.83

–

–

RPL18*

RIBOSOMAL PROTEIN

L18

Ssc.10553.1.A1_a_at

Internal Reference

45

6

0.43

0.50

–

–

RPL18*

RIBOSOMAL PROTEIN

L18

Ssc.10553.1.A1_a_at

Internal Reference

65

6

0.62

0.91

–

–

RPL18*

RIBOSOMAL PROTEIN

L18

Ssc.10553.1.A1_a_at

Internal Reference

85

6

0.21

0.44

–

–

RPL18*

RIBOSOMAL PROTEIN

L18

Ssc.10553.1.A1_a_at

Internal Reference

105

6

0.26

0.51

–

–

*Denotes DCt values normalized with RPL18.
1
Denotes significances p,0.05.
doi:10.1371/journal.pone.0055345.t001

(Table 4). Analysis using the canonical pathways [52,71] revealed
upregulation of mevalonic acid and HMG-CoA reductase
pathways in Meishan placental tissues. This observation is likely
to contribute to the principal increases observed by expression
profiling in sterol metabolism [72], as MVK is a major component
of both cholesterol and terpenoid pathways [73]. Taken together,
cholesterol metabolism genes showing significant differential
expression were CYP51A1, EBP, FDFT1, FDPS, HMGCS1, IDI1,
MVD, MVK, SC5DL, SQLE, SREBF2 and TM7SF2 (Figures 4, 5).
The biochemical committed step in cholesterol synthesis is
catalyzed by squalene epoxide (p,0.02, Figure 4A) [74]. Our
analysis revealed several genes epistatic to the catalytic step for
commitment of cholesterol synthesis, e.g. FDPS, FDFT1, HMGCR,
IDI1, MVK, MVD (Table 5, Figures 4, 5), and upregulation may
serve to modulate flux through multiple sterol pathways, e.g.
isoprenoid (261025, Table 3). Intriguingly, DHCR7, an enzyme
that mediates the last catalytic step for cholesterol synthesis, is
downregulated with respect to Meishan. DHCR7 (Figure 4B, RTqPCR p,5.8261028) is also implicated as a negative regulator of
the hedgehog signaling cascade, and we speculate downregulation
may serve to increase SHH signaling in the placenta.

5 Cholesterol Synthesis Differences Predicted by Gene
Ontology and Pathway Analysis
A common approach to clarify transcriptome datasets is to
enrich for functionality using the controlled gene ontology
vocabulary of molecular function, biological process and cellular
component. By annotating gene lists with GO terms, the goal is to
reduce the complexity of the data in such a way that differentially
expressed genes can be targeted to a common process(es) which
can be investigated further. The Database for Annotation,
Visualization, and Integrated Discovery, commonly referred to
as DAVID (9) allowed us to explore coordinated biological
processes in the placental datasets and unveiled cholesterol
biosynthesis (GO: 0006695, p,161025) as the top-ranked
molecular term describing differences between the pig breeds
(Table 3).
Mapping enriched genes into established metabolic pathways is
an attractive approach to deconstruct molecular phenotypes from
microarray datasets. To better visualize the fraction of microarray
data contributing to canonical such as KEGG [52] networks, we
used Ingenuity Pathway Analysis (IPA). As data input, we used
differentially expressed genes (q ,0.05) to construct the networks
PLOS ONE | www.plosone.org
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Figure 2. XIST structure and transcription in Meishan and WC placentas; expression of a short isoform in the Meishan breed. Swine
XIST was discovered and annotated from reciprocal BLAT with bovine XIST as it is not annotated in the current pig 9.2 genome assembly. (A)
Specifically, we identified BAC CH242-76N1 (GI: 219925014) that contained porcine XIST. Biochemical studies involving mutated or truncated XIST
transcripts revealed the A-repeat region as the functional element responsible for X-chromosome inactivation [65]. We mapped Affymetrix probesets
and the corresponding ESTs to porcine XIST and designed a series of RT-qPCRs (bracketed numbers) to validate microarray results (Table 1). (B)
Agarose gel electrophoresis depicting representative PCR assays to amplify regions of genomic DNA or cDNA from D25 MS or WC fetuses for the
chromosomal interval SSCX: 58,375,000-58,400,000 based on the assembly (SGSC Sscrofa9.2/susScr2 and BAC CH242-76N1 (GI: 219925014). A postive
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control for genomic DNA isolation is shown for COL10. For analysis of placental RNA isolation and cDNA generation, we performed reversetranscription PCR with exon-spanning primers for the positive control RPL18 (Figure 2B, bottom panel, lanes 2+3). The short XIST isoform was absent
from additional MS gestations (Table 1).
doi:10.1371/journal.pone.0055345.g002

observed upregulation of cholesterol synthetic genes between D45
and D65 in the Meishan placentae (Figure 5).
We next measured free and esterified cholesterol levels in
placental tissue homogenates by a fluorometric Amplex Red assay.
Cholesterol concentrations were similar at D25 for both breeds.
However, increased cholesterol production in the Meishan
placental tissues was detected at D45 and continued throughout
gestation (Figure 6).

Placental differences in cholesterol homeostasis through transcriptional activation programs, transport mechanisms and membrane specialization were also revealed by pathway analysis
(Figure S2). Transcriptional control of cholesterol metabolism is
mediated in part by sterol regulatory element binding proteins
(SREBP), e.g. SREBF2 (q ,0.02; Table 5), in which binding of the
cholesterol ligand yields nuclear translocation and de novo
transcription at sterol consensus binding sequence target genes
[75]. Cholesterol metabolism, reverse cholesterol transport,
lipoprotein remodeling, lipogenesis and cholesterol efflux are
controlled in part by modulating transcriptional activation of the
nuclear liver 6 receptor (LXR) and retinoic acid (RXR) complex
(p,0.05; Table 4, Figure S2) [75–76].

7 Extraction of Endothelial Biomarkers from Array
Datasets to Assess Breed-specific Placental Vascularity
Differences
As shown in Figure 7, endothelial cell markers increased during
gestation as would be expected due to increased placental
vascularization as the pregnancy progresses. Differences (COLEC11 (p,0.01), ENG (p,0.03), PECAM1 (p,0.03) and a trend
towards significance of CDH5 (p,0.08) were observed at D45 and
D65 with increased expression in the White Composite compared
to Meishan.

6 RT-qPCR and Biochemical Analyses Support Differences
in Cholesterol Biosynthesis
To confirm that the cholesterol synthesis pathway was affected,
we analyzed a subset of cholesterol genes in the D65 samples by
RT-qPCR and as shown in Figure 4B, the data supports GO and
pathway analyses. Moreover, the observed upregulation at D65 in
the Meishan was not due to the presence of the single male
placental sample (D65_MS_B) as the RT-qPCR results showed
that this sample was not an outlier. This observation is also
supported by the similar variances between the Meishan and WC
samples shown in Figure 4B. Additionally, to more clearly visualize
cholesterol biosynthetic changes throughout gestation in each of
the two breeds, we plotted normalized expression of the different
cholesterol pathway enzymes over time (gestational interval) and

Discussion
In order to identify fundamental differences in gene expression
patterns between the WC and Meishan breed of swine we
compared their transcriptome throughout gestation. Linear mixed
models analysis looking at breed effects identified 1,595 differentially expressed genes at q,0.05. A shown in Fig. 1, XIST was
highly down regulated in the Meishan breed. As XIST is
responsible for epigenetic silencing of one female X-chromosome,

Figure 3. Non-random distribution of Meishan versus WC differentially expressed genes along the X-chromosome. A bubble plot is
depicted for the swine X chromosome (SSCX) in which physical coordinates are plotted (abscissa, x-axis) against sign-ranked –log10(p-values)
(ordinate, y-axis). Estimate values from the linear mixed model were used to calculate positive (Meishan) or negative (WC) signs. Each bubble
represents a specific probe set printed on the short-oligonucleotide array.
doi:10.1371/journal.pone.0055345.g003
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Table 2. Gene expression and DIGMAP analysis of Sus scrofa chromosome X.

Band

p-value

Gene

Description

Xq13

2.29E-04*

CHIC1

cysteine-rich hydrophobic domain 1

DLG3

discs, large homolog 3 (neuroendocrine-dlg, Drosophila)

IL2RG

interleukin 2 receptor, gamma (severe combined immunodeficiency)

OGT

O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl
transferase)

PIN4

protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin)

RNF12

ring finger protein 12

RPS4X

ribosomal protein S4, X-linked

SH3BGRL

SH3 domain binding glutamic acid-rich protein like

SNX12

sorting nexin 12

TAF9B

TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa

XIST

X (inactive)-specific transcript

YIPF6

Yip1 domain family, member 6

ZMYM3

zinc finger, MYM-type 3

ARMCX1

armadillo repeat containing, X-linked 1

ATRX

alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)

CHM

choroideremia (Rab escort protein 1)

COX7B

cytochrome c oxidase subunit VIIb

NAP1L3

nucleosome assembly protein 1-like 3

PABPC5

poly(A) binding protein, cytoplasmic 5

SRPX2

sushi-repeat-containing protein, X-linked 2

ARID4B

AT rich interactive domain 4B (RBP1- like)

CASK

calcium/calmodulin-dependent serine protein kinase (MAGUK family)

CFP

complement factor properdin

EBP

emopamil binding protein (sterol isomerase)

FUNDC1

FUN14 domain containing 1

Xq21

Xp11

2.94E-02*

5.05E-02*

KLF8

Krüppel-like factor 8

MAGED2

melanoma antigen family D, 2

RGN

regucalcin (senescence marker protein-30)

TFE3

transcription factor binding to IGHM enhancer 3

*Denotes significant at adjusted p-value ,0.05.
doi:10.1371/journal.pone.0055345.t002

which results in chromosomal dosage compensation [77], we
examined the expression of other X-linked genes and found no
evidence for abnormal X-chromosome inactivation. We followed
up this observation with a series of PCR assays that spanned the
length of both genomic and RNA XIST biotypes and concluded

from these experiments that (1) the A-repeat element is expressed
in both breeds of swine placentae; (2) breed-specific XIST isoforms
are readily detected by microarray and PCR methods; and (3) the
breed-specific isoforms are not due to structural breed-specific
differences in the XIST locus (Figure 2). While aberrant Xist
expression can affect developmental outcomes, as has been shown
in mouse embryos that ectopically expressed Xist from the active X
chromosome after nuclear reprogramming by somatic cell nuclear
transfer [78], it is not known what developmental outcome
expression of different Xist isoforms may have. In mice, two
distinct and developmentally regulated Xist isoforms (referred to as
large and small) have been identified that differ in their 3’ end
[79]. In mice, it is the large Xist form that seems to play a key role
in embryonic and fetal X-inactivation. What is unusual in these
two pig breeds is that the two isoforms are not developmentally
regulated but are breed-specific. That is, the large XIST form is
unique to the White composite, and is expressed throughout
gestation, not just at a specific developmental time point (Table 1).
While we have no direct evidence that the two isoforms lead to
differences in X-inactivation, the DIGMAP data is suggestive of

Table 3. Summary of top-ranking common gene ontology
(GO) molecular processes in swine placentae.

Gene Ontology

P-value for MS-WC

cholesterol biosynthesis

0.00001*

peroxisome

0.00001*

isoprenoid biosynthesis

0.00002*

pigmentation

0.00066*

nuclear heterochromatin

0.00082*

*Denotes significance at p,0.05 after multiple correction testing.
doi:10.1371/journal.pone.0055345.t003
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Table 4. Summary of Ingenuity ranked canonical (KEGG) pathways.

Ingenuity Canonical Pathways

2log(B-H p-value)

Genes
MVD, FDPS, FDFT1, EBP, CYP7B1, IDI1, MVK, NQO1, HMGCR, SC5DL

Biosynthesis of Steroids

4.12*

Antigen Presentation Pathway

2.35*

HLA-DMA, HLA-DRB4, HLA-A, HLA-B, HLA-DRB1, CANX, TAP1, HLA-C

Glutathione Metabolism

2.07*

MGST1, MGST2, GSTA4, GSTM3 (includes EG:2947), GSTA1, G6PD, GGT6, IDH2, GPX7, ANPEP,
GSTO1

LPS/IL-1 Mediated Inhibition of
RXR Function

1.94*

MGST1, GSTM3 (includes EG:2947), GSTA1, ABCB11, ACSL6, GSTO1, ABCA1, LY96, SULT4A1,
GSTA4, UST, MGST2, MAP3K7, SLC27A6, FABP4, XPO1, NR5A2, LBP, PLTP, TNFRSF1B, ACOX3,
HMGCS1, CYP4A11, ALDH7A1

Complement System

1.93*

C1R, C1S, CD55, C1QC, C1QA, CD46, C1QB

LXR/RXR Activation

1.88*

RXRG, LY96, CCL2, FASN, ACACA, LBP, PLTP, TNFRSF1B, HMGCR, HADH, ABCA1

Valine, Leucine and Isoleucine Degradation 1.88*

HSD17B10, PCCA, ACAD8, ECH1, ELOVL2, OXCT1, AOX1, HMGCS1, HADH, ALDH7A1, MCCC2

Hepatic Fibrosis/Hepatic Stellate Cell
Activation

MYH10, CCR5, VEGFB (includes EG:7423), CTGF, MYL6, EDNRB, MMP2, COL1A2, COL1A1,
LY96, CCL2, IGFBP3, LBP, TNFRSF1B, A2M, EGFR, COL3A1

1.82*

Caveolar-mediated Endocytosis Signaling

1.66*

FYN, HLA-A, ACTB, CD55, ITGA2, COPA, HLA-B, ACTG1, EGFR, HLA-C, COPG

Arachidonic Acid Metabolism

1.65*

TMEM87B, CYP4A22, CYP2U1, PLA2G10, PTGS1, YWHAZ, GGT6, CYP2D6, GPX7, PLOD1,
CYP1B1, LAMB2, PTGES3 (includes EG:10728), MGST2, CYP19A1, CYP4B1, CYP4A11, CYP51A1

Actin Cytoskeleton Signaling

1.59*

MYH10, TIAM1, PFN1, PIK3C2A, MYL6, ARPC1B, GRB2, ACTB, GNA12, ITGA2, C3ORF10,
PIKFYVE, GSN, ACTG1, PDGFC, PTK2, PAK1, TIAM2 (includes EG:26230), FGF23, PPP1R12A,
DIAPH2, LBP, PDGFD, PPP1CA

Fatty Acid Metabolism

1.47*

HSD17B10, CYP4A22, ACSL6, ECH1, CYP2D6, CYP1B1, CYP19A1, PECI, CYP4B1, ACAD8,
SLC27A6, ACOX3, CYP4A11, HADH, CYP51A1, ALDH7A1

Aryl Hydrocarbon Receptor Signaling

1.36*

MGST1, GSTM3 (includes EG:2947), GSTA1, NQO1, SMARCA4, GSTO1, CYP1B1, RXRG, CCND2,
PTGES3 (includes EG:10728), CCNA1, MGST2, GSTA4, NFIB, CDK2, ALDH7A1

Type I Diabetes Mellitus Signaling

1.32*

HLA-DMA, JAK1, ICA1, CD28, IKBKG, NFKBIA, HLA-A, MAP3K7, HLA-B, TNFRSF1B, SOCS5, CPE,
HLA-C

*Denotes significance greater than 1.30, corresponds to –(log of Benjami-Hochberg corrected p-value ,0.05.
doi:10.1371/journal.pone.0055345.t004

differences in X-chromosome behavior in the placenta of the two
breeds. We described three chromosomal bands on Sus scrofa X
(Xq13, Xq21, Xp11) that were significantly different between the
two breeds. Additionally, genetic crosses between the Meishan and
the WC support X-chromosome transcriptional differences
[12,69], further reinforcing our own observations.
The imprinted gene family represents a unique cluster of genes
that broadly contribute to mammalian developmental potential,
fetal growth and normal physiology of the placenta. Although the
biological functions of imprinted genes range diversely from
growth factors to transcription factors, many function to regulate
fetal and placental growth and often lead to embryonic lethality
when inactivated by knockout gene-targeting studies. Indeed,
genetic rescue in trans of a disrupted imprinting control region
completely ameliorated placental defects (placentomegaly). Because imprinted genes collectively play critical roles in fetoplacental development, we reasoned their expression pattern
might be particularly important during gestation between the MS
versus WC breeds. A recent study by Zhou et al 2009 [80]
comparing placental transcriptome profiles at D75 and D90 of
gestation between the prolific Chinese indigenous Erhualian versus
Western composite breed identified several differentially expressed
imprinted genes DIRAS3, DIO3, NAP1L5, PON2, PLAGL1 and
SDHD. Taken together both functional and expression profiling
studies of imprinted genes warrant their relevancy for targeted
exploratory analysis in our placental transcriptome datasets.
Expression data presented in Table S2, survey imprinted genes
that met significance criteria at q ,0.05. Breed specific differences
were observed for several imprinted genes. Three paternally
expressed genes, NAP1L5, SNORD107, SNRPN and the maternally
expressed PHLDA2 showed significantly higher expression in
PLOS ONE | www.plosone.org

Meishan placentae. In WC placentae, significantly higher expression of paternally expressed IGF2, INPP5F, MEST, PEG10, PEG3
and maternally expressed IGF2R, MEG3, OSBPL1A were observed.
In addition to differences in behavior of X-chromosome linked
genes and imprinted genes, lipid and cholesterol metabolism,
cholesterol transcriptional activation and transport were identified
as being different between the two breeds and forms the basis for
the model presented in Figure 8. Placental synthesis, transcriptional activation, and transport of cholesterol differ between breeds
of swine. We propose a model of differential cholesterol utilization
in the placentae of Meishan and White Composite swine breeds
(Figure 8). Specifically, the model predicts:
1) Increased cholesterol biosynthetic activity in Meishan
placentae. Evidence for the increased synthesis of cholesterol in

Meishan placentae is supported by microarray observations, RTqPCR, pathway analyses and biochemical determination of
cholesterol levels. Cholesterol metabolic genes were upregulated
by D65 and point to increased biosynthetic flux of cholesterol
consistent with microarray and RT-qPCR findings (Figures 4, 5).
Additionally, free and esterified cholesterol concentration differences support increased activity in Meishan placentas by D45, and
these increased levels are maintained throughout gestation
(Figure 6). While we have not measured cholesterol intermediates
and oxidation products (oxysterols), these may refine or clarify
differences in cholesterol signaling between swine breeds. Functional studies using small molecule inhibitors that selectively target
synthetic enzymes of cholesterol metabolic enzymes such as
squalene synthase, e.g. FsPP, BPH-652, BPH-698, BPH-700, may
also lend clues to these differences.
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Figure 4. Gene targets enriched in Gene Ontology and KEGG cholesterol biosynthetic pathways. (A) Collective analyses by DAVID and
Ingenuity pathway tools indicated significant upregulation of sterol biosynthesis (cholesterol) in the placentae of Meishan breed. Using the KEGG
cholesterol biochemical pathway as a template, we mapped expression pattern differences (yellow, upregulation in MS; blue, downregulation in MS)
corresponding to placental expression breed differences at D65. The final catalytic step of cholesterol production is mediated by the reductase
DHCR7, an imprinted gene [40]. (B) Bar graphs indicating relative quantitation by EvaGreen RT-qPCR of D65 placentae were used to determine gene
expression intensities of a subset of cholesterol biosynthetic genes. Normalization across biological replicates and breed groups were performed
using housekeeping gene RPS20. A two-tailed heteroscedastic Student t-test was used to report significance (p,0.05). Error bars reflect standard
error of the mean for three placental samples after three repeated measurements of the same group (technical replicates).
doi:10.1371/journal.pone.0055345.g004

placentae? We hypothesize that upregulation of ABCA1 in WC
placentae enhances the kinetics of efflux of maternally-derived
cholesterol; that is, as cholesterol diffuses or is moved across the
endometrium into the fetal side, ABCA1 may serve as an
alternative route to partially compensate for reduced local
placental cholesterol synthesis. While there is conflicting evidence
in the literature with respect to human trophoblastic ABCA1

2) Differences in transport or kinetics of cholesterol
efflux partially compensate for reduced local synthesis
routes in WC placentae. Transport of cholesterol by efflux and

intracellular mechanisms differs between swine breeds. In contrast
to Meishans where cholesterol is locally synthesized in the
placenta, our data supports increased ABCA1 activity in WC
placentae. Why might transport be different in the swine
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Figure 5. Temporal changes in cholesterol biosynthesis gene expression throughout gestation. To visualize and identify patterns of
gene expression, the KEGG cholesterol biosynthetic genes were plotted at each gestational time point (x-axis) using mean intensities (y-axis) of
normalized microarray data. Arrows denote the metabolic flux through biochemical pathway: that is, the biochemical steps in which acetyl coenzyme A is processed into cholesterol. A shaded grey box is overlaid for convenience to show the D45–D65 breed-specific cholesterol pattern.
doi:10.1371/journal.pone.0055345.g005

subcellular localization and its function in maternal-fetal cholesterol efflux [81], treatment with the ABCA1-inhibitor glyburide
decreased cholesterol efflux relative to controls [82]. Additionally,
small molecule complementation with a LXR agonist can induce
Abca1’s expression in wild-type mouse littermates, and increase
rates of maternal-fetal cholesterol transfer to the fetus [83]. Our
data also points to differences in intracellular movement of
cholesterol. Movement of cholesterol out of late endosomes is
mediated by NPC2; this was downregulated (q ,4.061024;
Table 5, Figure S2) in the Meishan placentae. Shuttling cholesterol
between the plasma membrane and endoplasmic reticulum is
mediated in part by the oxysterol-binding protein OSPBL3 (q
,4.061024; Table 5, Figure S2), and this transport mode is
reduced in Meishans. Curiously, subcellular immuno-staining of
human ABCA1 in larger trophoblast villi also localized the protein
to the endoplasmic reticulum [81] and implicated ABCA1 as a
mediator to expel cytotoxic oxysterols from the placenta [82].
Placental trophoblast cells may use additional modes of cholesterol
efflux including secretion through complexing of apolipoproteins
or lipoproteins, and we document differences in apolipoprotein
remodelers, e.g. LPL, LCLAT1, PLTP (Table 5, Figure S2) [84].
PLOS ONE | www.plosone.org

3) Differences in transcriptional circuits for cholesterol
synthesis and movement between swine breeds. Genome-

wide expression profiling revealed striking differences in cholesterol synthetic and transport enzymes, and this begs the question:
is cholesterol homeostasis in the placentae differently regulated at
the transcriptional level? Indeed, we observed upregulation in
sterol response binding transcription factor SREBF2 (q ,0.02;
Table 5, Figure S2) that facilitates transcriptional activation of
cholesterol metabolic enzymes. Supporting this view, we also
documented upregulation of the entire suite of cholesterol
biosynthetic enzymes (except the notable exception DHCR7),
presumably mediated through upregulation of SREBF2. Cholesterol efflux is coordinated, in part, by transcriptional activation of
the nuclear liver X receptor and (LXR) and retinoic acid (RXR)
complex (p,0.05; Table 4, Figure S2). Differences in hetero- and
homo-dimerization partners of LXR and RXR isotypes as well as
ligand binding are implicated in the wide ranging physiological
processes of reverse cholesterol transport, lipoprotein remodeling,
lipogenesis, and cholesterol efflux among others [75,76]. Additionally, recent biochemical studies support a role of transcriptional regulation by TACC1 (highly expressed in MS placentas),
12

January 2013 | Volume 8 | Issue 1 | e55345

cytochrome B5
reductase 3

cytochrome P450,
family 4, subfamily
b, polypeptide 1

cytochrome P450,
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21.4760.071

3-hydroxy-3methylglutaryl-coA
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0.3360.042

1.9760.041
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21.3960.069
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0.8960.218

0.9260.165

1.8960.157

20.2860.099
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20.0960.091
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Mean+StD

cholesterol
biosynthesis
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biosynthesis
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emopamil binding
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apolipoprotein F
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cholesterol
biosynthesis

atp-binding
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Gene
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Gene
Description

2.3960.039

20.8960.012
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0.0860.036
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1.4660.188

1.3260.092
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D45 MS
Mean+StD
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1.4860.053
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20.0960.035

2.0860.132
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2.360.034

2.6660.301
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Mean+StD

Table 5. Breed-specific microarray expression levels of sterol biosynthesis genes identified as enriched by Ingenuity Pathway Analysis.
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2.1560.185
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2.2360.164
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1.43 q ,2E8*
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*Denotes significant at adjusted q-value ,0.05.
doi:10.1371/journal.pone.0055345.t005
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,0.04*

21.3 q
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Figure 6. Biochemical analysis of cholesterol concentrations in swine placentae. (A) Free and (B) esterified cholesterol concentrations were
measured in swine placentae by the Amplex Red assay at each gestational interval. No differences in free or esterfied cholesterol concentrations were
observed at D25. At D45, both free and esterified cholesterol levels showed significant differences. These differences in cholesterol concentration by
breed were maintained throughout gestation at the sampled time points. Error bars reflect standard error of the mean for six placental samples with
three repeated measurements of the same group (technical replicates).
doi:10.1371/journal.pone.0055345.g006

Figure 7. Differential expression of endothelial markers across gestation in swine placentae. Canonical biomarkers specific to endothelial
cells were used as a surrogate measure of placental vascularity. Biomarkers are plotted by gestational time with respect to normalized expression.
Asterisks denote corrected multiple-testing significance (p,0.05) and crosses denote a trend (p,0.1). Multiple plots are shown for FLT1 and PECAM,
and this reflects the gene estimate measurements for each of the multiple probe sets printed on the short-oligonucleotide array.
doi:10.1371/journal.pone.0055345.g007
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Figure 8. Model of cholesterol utilization in swine placentae. Combined, our results support differential cholesterol synthesis, transport and
transcriptional activation in the placentae of two breeds of swine. Specifically, our results predict 1) increased cholesterol biosynthetic activity in
Meishan placentae, 2) increased cholesterol efflux by transporters ABCA1 towards the fetal blood lumen in WC placentae and 3) increased gene
expression by transcriptional activation of cholesterol enzymes mediated in part by SRE-binding proteins and RXR/LXR signaling in Meishan.
doi:10.1371/journal.pone.0055345.g008

no differences were observed in either breed; however, at D45
breed vascularity markers became apparent with significant
upregulation in WC of ENG (p,0.03) and a trend towards
significance of CDH5 (p,0.08). Upregulation of CDH5 was noted
in WC in D65 and D85 gestations and a trend in D105 gestations;
in comparison, ENG did not exhibit breed specific differences in
subsequent gestational time points. Furthermore, no statistical
differences were observed for the vascular endothelial growth
factor receptor 1 also known as FLT1 or VEGFA (See Figure 7) and
VEGFC (data not shown). VEGFB was expressed higher in WC
(21.2, q ,0.01; data not shown), but its expression decreased
throughout gestation. Overall, however, our data does not support
increased vascularity in the Meishan placenta as has been reported
previously (Figure 7).

and its interaction with nuclear receptors devoid of their respective
ligands (aporeceptors) including AR, RXRa, RARa, PPARc,
ERa, GR, TRa1 and TRa2 [85]. In short, mechanisms that
regulate proper cholesterol homeostasis via transport and biosynthesis are crucial to reproductive fitness [86]. The ability to
manipulate the flux of cholesterol from mother to fetus and
modulate local biosynthetic routes in the placenta could improve
fetal growth trajectories, enhance pregnancy outcomes, and
reduce neonatal loss [87,88].
Finally, previous studies suggested that Meishan enhanced
placental efficiency compared to occidental breeds may be due to
increased vascularity [89,90]. Concordant with these reports,
recent experiments carried out on the placentas of Taihu pig
strains (Meishan and Erhualian) and comparison to Western
breeds also support increased placental angiogenesis. For example,
a gene expression survey of D75 and D90 placentae from the
prolific Chinese Erhualian breed as compared to the Large White
reported that VEGF pathway genes responsible for angiogenesis
were overrepresented in Erhualian placentae [80]. Wu et al, 2009
reported similar increases for VEGF signal transduction genes in
Erhualians, but observed a decrease in vascular endothelial
cadherin (CDH5) and b-arrestin 2 (ARRB2) when compared to
Landrace breeds [27]. The swine placenta is composed of multiple
cell types including trophoblast epithelial cells that form the
chorionic bilayer and endothelial cells that comprise blood
capillaries and line blood vessels. Analysis of multiple endothelial
markers, e.g. COLEC11, ENG, PECAM1, CDH5, extracted from
our transcriptome datasets indicated higher expression levels in the
White Composite compared to Meishan. In addition to extracting
these biomarkers, we analyzed VEGFA, VEGFB, VEGFC, the
VEGF receptor FLT1. Later stages of gestation in both breeds had
higher total amounts of endothelial cell markers (CDH5, ENG)
which we infer to have increased amounts of vascularity. At D25
PLOS ONE | www.plosone.org

Summary
We sought to investigate gene expression differences between
commercial swine populations and the Chinese Meishan placentae
to potentially uncover candidates for placental efficiency [91]. Our
findings include differences in XIST isoforms expression between
the two breeds, differences in X-chromosome gene expression as
identified by DIGMAP, and marked differences in lipid and
cholesterol biosynthesis and transport between the two breeds. We
have also confirmed these results by quantitative real-time PCR,
and directly measured physiological concentrations of cholesterol.
Specifically, these analyses reveal a number of common and
unique candidate genes that may confer enhanced placental
efficiency through modulation of steroid biosynthetic pathways.
This report provides information to target physiological studies in
any swine population to see if modulation of cholesterol
biosynthetic pathways can favorably influence placental efficiency
and fetal survival.

17

January 2013 | Volume 8 | Issue 1 | e55345

Placental Gene Expression in Two Swine Breeds

SREBF2 is upregulated in Meishans and may explain why the
cholesterol synthetic enzymes are overexpressed in Meishan
placentae. A description of IPA symbols is provided in Figure S3.
(TIFF)

Supporting Information
Figure S1 2-Dimensional PCA of swine placental changes at 20 day gestational intervals. To scrutinize the behavior
of individual microarrays, we used mathematical deconstruction
by principal component analysis in order to visualize global
changes of gene expression throughout gestation in swine
placentae. The distance or proximity of each plot to neighboring
plots indicates relative similarity. Ellipses were manually drawn to
better visualize intra-sample variation for breed and gestational
day.
(TIFF)

Figure S3

Symbols used in Ingenuity Pathway Analyses.

(TIFF)
Table S1 Primers used in this study for RT-qPCR and
identifying XIST structure.
(DOCX)
Table S2 Summary of placental gene expression differences.

(PDF)

Figure S2 Comparison of LXR/RXR and SREBF2

signaling cascade in swine D65 placentae from WC and
Meishan. Pathways analysis facilitated the identification of sterol
transcriptional activation circuits previously unrealized by gene
ontology analysis. The diagram depicts gene expression breed
differences in swine placentae of the LXR/RXR and SREBF2
signaling cascades. The blue to yellow color intensity denotes
downregulation in Meishan (blue) or upregulation in Meishan
(yellow). Cholesterol metabolism, reverse cholesterol transport,
lipoprotein remodeling, lipogenesis, and cholesterol efflux are
controlled in part by modulating transcriptional activation of the
LXR/RXR complex. In the presence of agonists including
oxysterols and 9-cis-retinoic acid, transrepression mediated by
NCORs is overcome to produce mRNAs of LXR/RXR target
genes. A downstream target of LXR/RXR transcriptional
activation is ABCA1 and this transmembrane protein is responsible
for movement of cholesterol out of the trophoblast (efflux) to HDL.
Coincident with this, lipoprotein remodeling proteins that alter the
discoid to spherical shape of HDL and intracellular cholesterol
transporters e.g. NPC2, OSBPL1A, OSBPL3 and STARD3, are also
affected indicative of LXR/RXR transcriptional activation.
Regulation of the cholesterol biosynthetic pathway is controlled
in part by transcriptional activation of sterol binding protein.
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